*ST兆新(002256.SZ):決定出售虹彩新材料45%股權給華哲經緯
格隆匯7月21日丨*ST兆新(002256.SZ)公佈,公司於2021年7月21日召開了第五屆董事會第五十一次會議,審議通過了《關於出售子公司股權的議案》。為減輕公司債務負擔、提高運營和管理效率,推動公司健康發展,公司決定出售深圳市虹彩新材料科技有限公司(“虹彩新材料”)45%股權給深圳市華哲經緯生物科技有限公司(“華哲經緯”),交易成交金額為人民幣1260萬元。
此次交易將增加公司2021年度淨利潤161.90萬元(最終以年審會計師審計為準),將充實公司流動資金,加速對外債務的償付,有利於減輕公司的整體債務負擔。
公司曾於2020年12月31日出售虹彩新材料55%股權給深圳市數康威生物科技有限公司,交易成交金額為1540萬元;此次交易完成後,公司將不再持有虹彩新材料任何股份。根據《深圳證券交易所股票上市規則》的相關規定,此次交易尚需提交公司股東大會審議通過,不構成關聯交易,亦不構成《上市公司重大資產重組管理辦法》規定的重大資產重組。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.